PeerWell is Outcome Management (Healthcare) in United States that focus on chemotherapy candidates business. Founded in 2014. They cover business area such as developer, hip-and knee-replacement candidate, knee replacement, coronary bypass surgery, chemotherapy candidate, recovery, customized daily lesson, surgery and speed-up recovery, patient, major episode, care.
Outcome Management (Healthcare)
2014
( 10 years old in 2024 )
Chemotherapy Candidates
-
185 Channel Street
Suite 643
San Francisco, CA 94158
United States
Private
developerhip-and knee-replacement candidateknee replacementcoronary bypass surgerychemotherapy candidate, recoverycustomized daily lessonsurgery and speed-up recoverypatientmajor episodecare
* We use standard office opening hours in near PeerWell's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
PeerWell is Outcome Management (Healthcare) business from United States that founded in 2014 (10 years old in 2024), PeerWell business is focusing on Chemotherapy Candidates.
PeerWell headquarter office and corporate office address is located in 185 Channel Street Suite 643 San Francisco, CA 94158 United States.
PeerWell was founded in United States.
In 2024, PeerWell is currently focus on chemotherapy candidates sector.
Above is snippet of Google Trends for "chemotherapy candidates" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with PeerWell, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
